论文部分内容阅读
目的:探讨总结治疗由慢性阻塞性肺疾病所致重度呼吸衰竭患者的有效干预方案。方法:选取我院慢性阻塞性肺疾病且出现重度呼吸衰竭症状的患者共计30例作为研究对象,随机分组,15例患者为对照组,15例患者为干预组。对照组15例患者给予常规治疗。干预组15例患者在接受对照组常规治疗的同时应用BiPAP无创通气治疗方案。对两组患者接受治疗后的效果进行评估。结果:干预组患者临床治疗总有效明显高于对照组,数据对比存在显著差异,P<0.05,具有统计学意义。结论:应用BiPAP无创通气治疗方案对慢性阻塞性肺疾病所致重度呼吸衰竭患者疗效确切,值得推广应用。
Objective: To investigate the effective treatment of patients with severe respiratory failure caused by chronic obstructive pulmonary disease (COPD). Methods: A total of 30 patients with chronic obstructive pulmonary disease and severe respiratory failure in our hospital were selected as study subjects and randomly divided into 15 groups: control group and 15 patients as intervention group. Control group of 15 patients given conventional treatment. Fifteen patients in the intervention group received BiPAP noninvasive ventilation while receiving routine treatment in the control group. The effect of treatment on both groups was evaluated. Results: The total effective rate of clinical treatment in the intervention group was significantly higher than that of the control group, with significant differences in the data, P <0.05, with statistical significance. Conclusion: The application of BiPAP noninvasive ventilation is effective in patients with severe respiratory failure caused by chronic obstructive pulmonary disease, which is worthy of popularization and application.